Core One Labs is a life sciences company focused on novel psychedelic medicine delivery systems, advanced R&D, psychedelic-assisted psychotherapy treatment programs, and API grade psilocybin manufacturing in the mental healthcare sector.
Core One Labs
The company aims to develop and accelerate the commercialization of rapid onset treatments capable of improving results while also bringing a robust ROI for investors.
Since Core One Labs was founded in 2010, it has participated in 2 rounds of funding. In total Core One Labs has raised $4.0M. Core One Labs’ last funding round was on Dec 2020 for a total of $0.
“Developing psychedelic inspired medicines and experiential therapies to help tap into the mind’s own healing capabilities”
Activities
B2B
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates